Pfizer May Sell Animal Health Assets

According to a news article from Bloomberg, multiple parties expressed interest in the animal products, which the marketplace has viewed as ‘desirable,’ chief financial officer Frank D’Amelio said yesterday.

“In the US, we are actively engaged in negotiations in animal health,” Mr D’Amelio told Bloomberg. “There are parties that have expressed interest.”

Mr D’Amelio declined to elaborate on the bidding process. When Pfizer completes its purchase of Wyeth, it will have the world’s biggest animal health business, with about $4 billion in annual revenue, the company said.

Pfizer has said it may have to divest some of its animal assets. The company is unlikely to divest products with more than $400 million in annual revenue.

Sign up for our
regular news updates

Related news items:

•    Two Cases of ASF in Wild Boar
•    Swine Vesicular Disease Reported in Italy
•    Livestock Company Opens Feed Factory
•    Update on PRRS Elimination from AASV
•    EU Sets New MRL for Altrenogest

Related News Categories: Pig Health, Company/Products

Sign up for our
regular news updates

More of the latest Pig Industry News

•   2011 Pork Imports Higher Than a Year Ago
•   New Way to Map Drought and Water Use
•   Importers Face High Stocks & Weak Demand
•   Stepping Up Pressure for Practice in Rural Rat Control
•   December 2011 Retail Animal Feed Production Down
•   NSW Protection of the Environment Legislation
•   Precision Feeding Cuts Feeding Costs
•   China Pork Prices Higher in January
•   Further Discussion on Forthcoming EU Ban on Stalls
•   Weekly Roberts Market Report